Table 2. The correlation between RUNX2 expression in tumors and clinicopathological features of GC patients.
| Feature | RUNX2 expression (n = 305) | ||
|---|---|---|---|
| Low (n = 85) | High (n = 220) | P values | |
| Gender | |||
| Male | 60 | 146 | 0.480 |
| Female | 25 | 74 | |
| Age | |||
| < 60 years | 51 | 119 | 0.352 |
| ≥ 60 years | 34 | 101 | |
| Differentiation degrees | |||
| High | 15 | 29 | 0.012 |
| Moderate | 17 | 20 | |
| Low | 53 | 171 | |
| TNM Stages | |||
| TNM 1 + 2 | 49 | 75 | < 0.01 |
| TNM 3 + 4 | 36 | 145 | |
| Lymph node metastasis | |||
| Positive | 42 | 161 | < 0.01 |
| Negative | 43 | 59 | |
| Depth of invasion | |||
| Submucosa & Muscularis | 38 | 42 | < 0.01 |
| Serosa | 47 | 178 | |